Prestige Consumer Healthcare Inc. reported earnings results for the fourth quarter and full year ended March 31, 2024. For the fourth quarter, the company reported sales was USD 276.99 million compared to USD 285.87 million a year ago. Net income was USD 49.46 million compared to net loss of USD 240.55 million a year ago. Basic earnings per share from continuing operations was USD 0.99 compared to basic loss per share from continuing operations of USD 4.83 a year ago. Diluted earnings per share from continuing operations was USD 0.98 compared to diluted loss per share from continuing operations of USD 4.83 a year ago.
For the full year, sales was USD 1,125.36 million compared to USD 1,127.73 million a year ago. Net income was USD 209.34 million compared to net loss of USD 82.31 million a year ago. Basic earnings per share from continuing operations was USD 4.21 compared to basic loss per share from continuing operations of USD 1.65 a year ago. Diluted earnings per share from continuing operations was USD 4.17 compared to diluted loss per share from continuing operations of USD 1.65 a year ago.